“…Chemogenetic tools using mutated muscarinic acetylcholine receptors, called Designer Receptors Exclusively Activated by Designer Drugs (DREADDs), have been widely used in rodents and other small animals (Roth, 2016). DREADDs have also proven to be useful in nonhuman primates (NHPs), where they can manipulate neuronal activity in a specific cell type or neural pathway (Mimura et al, 2021;Oguchi et al, 2021;Perez et al, 2022) or simultaneously and discretely in multiple brain regions (Eldridge et al, 2016;Nagai et al, 2016Nagai et al, , 2020Raper et al, 2019;Hayashi et al, 2020;Hori et al, 2021;Oyama et al, 2021Oyama et al, , 2022Roseboom et al, 2021). As such, they provide an opportunity for identifying the regions and pathways that are causally responsible for cognitive/emotional functions.…”